-
Biotechs purr on clinical and deal-making news
19 Jun 2025 03:42 GMT
… and children with life-threatening, steroid-resistant GvHD, a common complication … Garfield the Cat Day, the biotech sector purrs with deals and …
-
Stem Cell Therapy Market to Surpass $45.6 Billion by 2033, Fueled by Regenerative Innovations | DataM Intelligence
20 Jun 2025 13:15 GMT
… &A activity among pharmaceutical, biotech, and academic institutions to expand … stem cell therapy for pediatric steroid-refractory acute graft-versus-host …
-
Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)
20 Jun 2025 05:00 GMT
… taper), or systemic non-steroidal immunosuppressive medications or immunomodulating … severe eosinophilic or oral steroid dependent asthma in adults … who also take a steroid medicine by mouth that … REGN) is a leading biotechnology company that invents, develops …
-
Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
20 Jun 2025 05:00 GMT
… OCS taper), or systemic non-steroidal immunosuppressive medications, or immunomodulating biologics … (NASDAQ: REGN) is a leading biotechnology company that invents, develops and …
-
Communiqué de presse : Dupixent est approuvé aux États-Unis comme le seul médicament ciblé pour traiter les patients atteints de pemphigoïde bulleuse
20 Jun 2025 05:00 GMT
… des médicaments immunosuppresseurs systémiques non stéroïdiens ou des agents biologiques immunomodulateurs … : REGN) est une société de biotechnologie de premier plan qui invente …
-
New Wave in gMG Care: Cutting‑Edge Biologics Transform Treatment Landscape | Competitive Intelligence
19 Jun 2025 18:42 GMT
… -cell targeting therapies.
- Emerging Biotechs are exploring RNA-based, tolerogenic … -private partnerships
Increased collaboration between biotech firms and academic institutions is … longer confined to long-term steroid use and symptom management. Today …
-
RGD-Functionalized Ginsenoside Rg3 Liposomes for Alleviating Oxidative Stress and Choroidal Neovascularization in Age-Related Macular Degeneration
19 Jun 2025 17:34 GMT
… cholesterol was from Dalian Meilun Biotechnology (Dalian, China). Soybean … were supplied by Chengdu Dashuo Biotechnology (Chengdu, China). Mice … that Rg3 possesses a steroid-like structure characterized by … Gao X, et al. Steroid-induced ocular hypertension/ …
-
Multiple Myeloma Market Poised for Breakthrough: Innovation, Unmet Needs, and Strategic Moves | Competitive Intelligence
19 Jun 2025 17:32 GMT
… players like Arcellx and Legend Biotech.
Target Opportunity Profile (TOP): What … syndrome), ICANS (neurotoxicity), and minimal steroid burden.
- Convenience: Oral or …
-
Dermatomyositis Market Set to Witness Significant Growth During the Study Period (2020–2034) Amid Rising Awareness and Advanced Treatments | DelveInsight
19 Jun 2025 17:00 GMT
… effectiveness and reduce the required steroid dose. Medications like azathioprine, … do not respond well to steroids alone, experience side effects, … , CSL Behring, Viela Bio, PAEAN Biotechnology, Alexion Pharmaceuticals, among others. Dermatomyositis …
-
Uveitis Treatment Market Size to Reach USD 4.69 Billion by 2032, Driven by Advancements in Biologics and Rising Prevalence of Autoimmune Disorders – SNS Insider
19 Jun 2025 13:51 GMT
… Photophobia) and the treatment (topical steroids basically).
By Distribution Channel, Retail … presence of key pharmaceutical and biotechnology companies. High R&D …
About
© 1995-2025